JPH07500330A - 関節のT細胞介在炎症の治療のためのCDw52特異抗体 - Google Patents
関節のT細胞介在炎症の治療のためのCDw52特異抗体Info
- Publication number
- JPH07500330A JPH07500330A JP5507528A JP50752893A JPH07500330A JP H07500330 A JPH07500330 A JP H07500330A JP 5507528 A JP5507528 A JP 5507528A JP 50752893 A JP50752893 A JP 50752893A JP H07500330 A JPH07500330 A JP H07500330A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- treatment
- drug
- cell
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2893—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.CDw52抗原を認識する抗体の、関節のT細胞介在炎症を治療するための 医薬の製造への使用。 2.前記抗体がヒト化抗体である請求の範囲第1項記載の使用。 3.前記抗体がCAMPATH−IHである請求の範囲第2項記載の使用。 4.リウマチ様関節炎を治療するための医薬の製造への、請求の範囲第1項ない し第3項のいずれか1項に記載の使用。 5.前記治療において、抗体を、1日当り1ないし約100mgの量で、1ない し30日の期間投与する請求の範囲第1項ないし第4項のいずれか1項に記載の 使用。 6.前記量が1日当り1ないし10mgである請求の範囲第5項記載の使用。 7.前記医薬が静脈内に投与されることに適合する請求の範囲第1項ないし第6 項のいずれか1項に記載の使用。 8.医薬が、他の免疫抑制抗体の同時もしくは連続投与を具備する方法による関 節のT細胞介在炎症の治療に用いられるためのものである請求の範囲第1項ない し第7項のいずれか1項に記載の使用。 9.前記他の免疫抑制抗体が抗CD4抗体である請求の範囲第8項記載の使用。 10.医薬が、ステロイドの同時もしくは連続投与を具備する方法による関節の T細胞介在炎症の治療に用いられるものである請求の範囲第1項ないし第8項の いずれか1項に記載の使用。 11.関節のT細胞介在炎症の治療に用いられる薬剤であって、該薬剤がCDw 52抗原を認識する抗体を含有する薬剤。 12.前記抗体がヒト化抗体である請求の範囲第11項記載の薬剤。 B.前記抗体がCMAPATH−IHである請求の範囲第12項記載の薬印。 14.リウマチ様関節炎の治療に用いられる請求の範囲第11項ないし第13項 のいずれか1項に記載の薬剤。 15.前記治療において、抗体を、1日当り1ないし約100mgの量で、1な いし30日間投与する請求の範囲第11項ないし第14項のいずれか1項に記載 の薬剤。 16.前記量が1日当り1ないし10mgである請求の範囲第15項記載の薬剤 。 17.静脈内に投与されることに適合する請求の範囲第11項ないし第16項の いずれか1項に記載の薬剤。 18.他の免疫抑制抗体の同時もしくは連続投与を具備する方法による関節のT 細胞介在炎症の治療に用いられる請求の範囲第11項ないし第17項のいずれか 1項に記載の薬剤。 19.前記他の免疫抑制抗体が抗CD4抗体である請求の範囲第18項記載の薬 剤。 20.ステロイドの同時もしくは連続投与を具備する方法による関節のT細胞介 在炎症の治療に用いられる請求の範囲第11項ないし第18項のいずれか1項に 記載の薬剤。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77559891A | 1991-10-15 | 1991-10-15 | |
US775,598 | 1991-10-15 | ||
GB9215749.4 | 1992-07-24 | ||
GB929215749A GB9215749D0 (en) | 1992-07-24 | 1992-07-24 | Medicaments |
PCT/GB1992/001884 WO1993007899A1 (en) | 1991-10-15 | 1992-10-14 | CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07500330A true JPH07500330A (ja) | 1995-01-12 |
JP3535155B2 JP3535155B2 (ja) | 2004-06-07 |
Family
ID=26301317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50752893A Expired - Lifetime JP3535155B2 (ja) | 1991-10-15 | 1992-10-14 | 関節のT細胞介在炎症の治療のためのCDw52特異抗体 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0610447B1 (ja) |
JP (1) | JP3535155B2 (ja) |
KR (1) | KR100264218B1 (ja) |
AT (1) | ATE174515T1 (ja) |
AU (1) | AU671807B2 (ja) |
CA (1) | CA2120911A1 (ja) |
DE (1) | DE69227918T2 (ja) |
DK (1) | DK0610447T3 (ja) |
ES (1) | ES2125977T3 (ja) |
IL (1) | IL103418A (ja) |
MY (1) | MY115415A (ja) |
WO (1) | WO1993007899A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9022543D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Antibody production |
GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
GB9603507D0 (en) * | 1996-02-20 | 1996-04-17 | Isis Innovation | Antibody variants |
GB2380127A (en) | 2001-09-26 | 2003-04-02 | Isis Innovation | Treatment of chronic joint inflammation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE95068T1 (de) * | 1988-02-12 | 1993-10-15 | British Tech Group | Modifizierte antikoerper. |
DE69028713T3 (de) * | 1989-12-27 | 2004-05-13 | Centocor, Inc. | Schimäre immunoglobuline für cd4-rezeptoren |
GB9022547D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Purified immunoglobulin |
-
1992
- 1992-10-14 DK DK93908763T patent/DK0610447T3/da active
- 1992-10-14 WO PCT/GB1992/001884 patent/WO1993007899A1/en active IP Right Grant
- 1992-10-14 JP JP50752893A patent/JP3535155B2/ja not_active Expired - Lifetime
- 1992-10-14 AT AT93908763T patent/ATE174515T1/de active
- 1992-10-14 MY MYPI92001857A patent/MY115415A/en unknown
- 1992-10-14 DE DE69227918T patent/DE69227918T2/de not_active Expired - Lifetime
- 1992-10-14 AU AU26985/92A patent/AU671807B2/en not_active Expired
- 1992-10-14 ES ES93908763T patent/ES2125977T3/es not_active Expired - Lifetime
- 1992-10-14 KR KR1019940701206A patent/KR100264218B1/ko not_active IP Right Cessation
- 1992-10-14 CA CA002120911A patent/CA2120911A1/en not_active Abandoned
- 1992-10-14 EP EP93908763A patent/EP0610447B1/en not_active Expired - Lifetime
- 1992-10-14 IL IL103418A patent/IL103418A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0610447A1 (en) | 1994-08-17 |
WO1993007899A1 (en) | 1993-04-29 |
AU2698592A (en) | 1993-05-21 |
ES2125977T3 (es) | 1999-03-16 |
KR100264218B1 (ko) | 2000-08-16 |
AU671807B2 (en) | 1996-09-12 |
ATE174515T1 (de) | 1999-01-15 |
JP3535155B2 (ja) | 2004-06-07 |
CA2120911A1 (en) | 1993-04-29 |
EP0610447B1 (en) | 1998-12-16 |
IL103418A0 (en) | 1993-03-15 |
IL103418A (en) | 1997-11-20 |
DE69227918D1 (de) | 1999-01-28 |
DE69227918T2 (de) | 1999-05-12 |
DK0610447T3 (da) | 1999-08-23 |
MY115415A (en) | 2003-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3383303B2 (ja) | CDw52−多発性硬化症の治療のための特異抗体 | |
ES2378446T3 (es) | Anticuerpos anti-TNF y metotrexato en el tratamiento concomitante de enfermedades autoinmunes | |
US11504426B2 (en) | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist | |
JP2017512193A (ja) | Il−4rアンタゴニストを投与することによる皮膚感染を処置するための方法 | |
Keystone et al. | Adalimumab therapy in rheumatoid arthritis | |
RU2607022C2 (ru) | Способы и композиции для лечения волчанки | |
CA3217278A1 (en) | Methods of treatment of autoimmune disorders using ilt7 binding proteins | |
RU2723047C2 (ru) | Средство для лечения множественной миеломы (ММ) | |
JPH07500330A (ja) | 関節のT細胞介在炎症の治療のためのCDw52特異抗体 | |
US20030211110A1 (en) | Pharmaceutical compositions and articles of manufacture useful in reversal of a clinical epiosode of an incurable disease and methods of use thereof | |
WO2021018191A1 (zh) | Il-17拮抗剂治疗自身免疫疾病的方法 | |
CA2060384C (en) | A pharmaceutical composition containing an antibody recognizing the cdw52 antigen | |
EP4334351A1 (en) | Treatment for systemic lupus erythematosus using anti-baffr antibodies | |
JP2024517796A (ja) | 抗baffr抗体を使用するループス腎炎の治療 | |
Lorenz | Share this story: RELATED ARTICLES | |
JPH03505088A (ja) | ホルモン類の作用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040210 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040311 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080319 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090319 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100319 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110319 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110319 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120319 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130319 Year of fee payment: 9 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130319 Year of fee payment: 9 |